Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A. (Q38884326)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A. (English)

1 reference

Europe PubMed Central

7 September 2017

0 references

0 references

1 reference

ORCID Public Data File 2021

author name string

Buonaguro L

1

1 reference

Europe PubMed Central

7 September 2017

Racioppi L

2

1 reference

Europe PubMed Central

7 September 2017

Tornesello ML

3

1 reference

Europe PubMed Central

7 September 2017

Arra C

4

1 reference

Europe PubMed Central

7 September 2017

Visciano ML

5

1 reference

Europe PubMed Central

7 September 2017

Biryahwaho B

6

1 reference

Europe PubMed Central

7 September 2017

Sempala SD

7

1 reference

Europe PubMed Central

7 September 2017

Giraldo G

8

1 reference

Europe PubMed Central

7 September 2017

Buonaguro FM

9

1 reference

Europe PubMed Central

7 September 2017

publication date

1 June 2002

1 reference

Europe PubMed Central

7 September 2017

Antiviral Research

1 reference

Europe PubMed Central

7 September 2017

54

1 reference

Europe PubMed Central

7 September 2017

3

1 reference

Europe PubMed Central

7 September 2017

189-201

1 reference

Europe PubMed Central

7 September 2017

Ugandan HIV-1 V3 loop sequences closely related to the U.S./European consensus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel glycoprotein 120 sequence from an HIV type 1 isolate of the A clade identified in North Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage therapy with regimens containing ritonavir and saquinavir in extensively pretreated HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and C

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tat toxoid as a component of a preventive vaccine in seronegative subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus-like gag-env particles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects. Community HIV Research Network Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Progress in the development of an HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression and self-assembly of empty virus-like particles of hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A molecular epidemiologic survey of HIV in Uganda. HIV Variant Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

An anti-HIV strategy combining chemotherapy and therapeutic vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Preventing AIDS but not HIV-1 infection with a DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Managing resistance to anti-HIV drugs: an important consideration for effective disease management.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic T cells and neutralizing antibodies induced in rhesus monkeys by virus-like particle HIV vaccines in the absence of protection from SHIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900004-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0166-3542(02)00004-9

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38884326&oldid=1589607780"